Larimar Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Larimar Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2013 to Q3 2024.
  • Larimar Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$18.3M, a 76.7% decline year-over-year.
  • Larimar Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$73.8M, a 93.9% decline year-over-year.
  • Larimar Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$41.8M, a 14.3% decline from 2022.
  • Larimar Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$36.5M, a 27.6% increase from 2021.
  • Larimar Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$50.5M, a 17.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$73.8M -$18.3M -$7.93M -76.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 -$65.8M -$24.6M -$15M -156% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$50.9M -$16.7M -$9.1M -119% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$41.8M -$14.2M -$3.72M -35.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 -$38M -$10.3M -$1.83M -21.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 -$36.2M -$9.62M -$933K -10.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$35.3M -$7.64M +$1.25M +14.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$36.5M -$10.4M -$1.35M -14.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$35.2M -$8.51M +$8.22M +49.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$43.4M -$8.69M +$3.86M +30.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$47.2M -$8.89M +$3.22M +26.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$50.5M -$9.09M +$5.31M +36.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 -$55.8M -$16.7M -$6.4M -61.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$49.4M -$12.5M -$1.14M -10% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$48.2M -$12.1M -$5.43M -81.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$42.8M -$14.4M -$16.8M -701% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 -$26M -$10.3M -$1.71M -19.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$24.3M -$11.4M -$7.7M -208% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$16.6M -$6.67M +$6.6M +49.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$23.2M $2.4M +$17.1M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 -$40.3M -$8.63M +$6.54M +43.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$46.8M -$3.7M +$11.9M +76.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$58.7M -$13.3M +$2.43M +15.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$61.1M -$14.7M -$1.33M -9.98% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 -$59.8M -$15.2M -$2.33M -18.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$57.5M -$15.6M -$2.02M -15% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$55.4M -$15.7M -$2.44M -18.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$53M -$13.4M -$2.88M -27.5% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-05
Q3 2017 -$50.1M -$12.8M +$1.99M +13.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$52.1M -$13.5M +$1.53M +10.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$53.6M -$13.3M +$4.59M +25.7% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-09
Q4 2016 -$58.2M -$10.5M +$12.8M +54.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-14
Q3 2016 -$71M -$14.8M +$4.89M +24.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$75.9M -$15.1M +$2.55M +14.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$78.4M -$17.9M -$4.62M -34.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$73.8M -$23.2M -$12.6M -118% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-09
Q3 2015 -$61.2M -$19.7M -$5.36M -37.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$55.9M -$17.6M -$11.6M -194% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 -$44.3M -$13.2M -$8.72M -193% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$35.5M -$10.7M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-10
Q3 2014 -$14.4M -$10.8M -308% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$5.99M -$3.01M -101% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$4.52M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q3 2013 -$3.52M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$2.98M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.